top of page
News, Events and Updates
Search
Sigma-1 Receptor Agonists Inhibit Oligodendrocyte Cytotoxicity Induced by Molecules
Feb 11, 2016
Anavex Reports Fiscal First Quarter 2016 Financial Results
Feb 8, 2016
Anavex to Present at 18th Annual BIO CEO & Investor Conference on February 9th 2016
Feb 2, 2016
14th International Athens / Springfield Symposium on Advances in Alzheimer Therapy
Feb 1, 2016
2016 Epilepsy Pipeline Conference
Jan 15, 2016
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2016
Jan 14, 2016
18th Annual CIO CEO & Investor Conference
Jan 12, 2016
Anavex Announces Positive Dose-Response Data for ANAVEX 2-73 in Alzheimer's Disease Patients
Jan 11, 2016
New Alzheimer's Drug ANAVEX 2-73: A Phase 2a Study, Clinical Safety, and Tolerability
Jan 11, 2016
31
32
33
34
35
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
